SureVax
Animal Bite Care
Vaccines
Lab Tests & Diagnostics
View all services
Quezon City
Manila & Central
East
South
View all 15+ branches Book Home Service
Anti-Rabies (Post-Exposure) Walk-in care, assessment, and first dose. Basic Wellness Essential blood, liver, kidney, and cholesterol tests. General Wellness A simple baseline health screening. Diabetes Work-Up HbA1c, blood sugar, lipids, and kidney tests.
Compare all packages

HPV Vaccine

Recommended for: Adolescents and young adults (ages 9–45), especially before HPV exposure.

Summary

The HPV-4 Vaccine (Gardasil) guards against four common strains of human papillomavirus (HPV): types 6, 11, 16, and 18. These strains cause most cases of cervical cancer and genital warts. Protection is strongest when given before HPV exposure — typically recommended for preteens, adolescents, and young adults.

HPV Vaccine

Facts about HPV Vaccine

Key things to know about the vaccine and how it works.

The HPV vaccine guards against cervical, anal, and other genital cancers, along with genital warts.

It targets high-risk HPV strains that account for the majority of HPV-related cancers.

The quadrivalent HPV vaccine covers two HPV strains linked to cancer and two strains that cause genital warts, offering broad protection against both.

Safe and well-tolerated, with common side effects like mild soreness at the injection site or temporary dizziness.

Optimal protection is achieved before HPV exposure, so the vaccine is typically recommended for preteens and young adults, though older individuals can still benefit if not previously vaccinated.

Who should get this vaccine

Should you get vaccinated? Who should consider the HPV vaccine and why?

Preteens and Adolescents
Vaccinating at a young age, typically between 9 and 14, ensures protection before any exposure to HPV. Since the immune response is stronger in younger individuals, early vaccination provides lasting immunity and lowers future risks of HPV-related cancers and infections.
Young Adults
For individuals in their teens and early 20s who may not have had prior exposure, the HPV vaccine offers valuable protection as they reach an age where HPV exposure becomes more likely. The vaccine reduces the chance of infection and its associated health risks, including cancers and genital warts.
Those with a Higher Risk of HPV Complications
For immunocompromised individuals or those with health conditions that increase cancer risk, the HPV vaccine provides a crucial preventive measure. It lowers the likelihood of severe HPV-related complications, helping maintain better long-term health.
Partners and Spouses
People with new or multiple partners, or those whose partners may be at risk, can benefit significantly from the vaccine’s preventive protection. By reducing HPV transmission, vaccination also helps protect partners and minimizes the spread of the virus within close relationships.
Healthcare and Public Health Workers
Healthcare professionals, especially those who may encounter HPV-positive patients, gain valuable protection with the HPV vaccine. Reducing their risk of infection also supports the broader goal of community health and reduces transmission rates. Preteens and Adolescents

Benefits

The Flu Vaccine (Quadrivalent) offers broad protection against four strains of influenza, reducing the risk of seasonal flu and promoting a healthier, more resilient immune system.

Prevents Cancer

The HPV vaccine significantly reduces the risk of HPV-related cancers, including cervical, throat, and genital cancers.

Contributes to Public Health

Widespread vaccination helps reduce the overall prevalence of HPV in the population, creating herd immunity and lowering transmission rates.

Enhances Peace of Mind

The vaccine reduces the stress and worry about contracting HPV-related diseases, allowing people to feel more secure in their health.

Empowers Preventative Care

The vaccine empowers individuals to take proactive steps in protecting their health, which can contribute to an overall sense of well-being and responsibility.

Promotes Gender-neutral Protection

The vaccine benefits all genders, offering protection across diverse populations and helping to reduce stigma associated with HPV.

Frequently Asked Questions

Answers to what patients ask most often about this vaccine.

What is the HPV-4 vaccine?

The HPV-4 vaccine (Gardasil) protects against four types of human papillomavirus (HPV): types 6, 11, 16, and 18. These strains are responsible for most cases of cervical cancer and genital warts

Who should get the HPV-4 vaccine?

Recommended for all adolescents aged 11-12 years Catch-up vaccination available for: Females aged 13-26 years Males aged 13-21 years Men who have sex with men through age 26 Immunocompromised individuals through age 26

How is the vaccine administered?

The vaccine is given as three separate shots over 6 months: First dose: Initial vaccination Second dose: 2 months after first dose Third dose: 6 months after first dose

What are the benefits of vaccination?

Prevents up to 90% of cervical cancers Prevents 90% of genital warts Protects against several other HPV-related cancers Provides long-lasting immunity

What are common side effects?

Most side effects are mild and include: Pain at injection site Swelling and redness Mild fever Headache Fatigue

Is the vaccine safe?

Yes. The vaccine has been extensively tested and monitored since its approval in 2006. Over 270 million doses have been administered worldwide with a strong safety record

Does insurance cover the HPV-4 vaccine?

Most private insurance plans cover the vaccine for recommended age groups. The Vaccines for Children (VFC) program provides free vaccines to eligible children. Check with your insurance provider or local health department for coverage details

Can I get HPV from the vaccine?

No. The vaccine contains virus-like particles but no live virus, making it impossible to get HPV from vaccination

Do vaccinated individuals still need cervical cancer screening?

Yes. Vaccinated individuals should still get regular cervical cancer screening as recommended by their healthcare provider, as the vaccine doesn't protect against all HPV types that can cause cancer

What if I miss a dose?

If you miss a dose, you don't need to restart the series. Schedule the missed dose as soon as possible and complete the remaining doses according to the recommended schedule. Recommended for all adolescents aged 11-12 years Catch-up vaccination available for: People with chronic health conditions Males aged 13-21 years Men who have sex with men through age 26 Immunocompromised individuals through age 26

Ready to protect yourself?

Book your vaccination today

Walk in or book ahead at any of our 15 SureVax branches across Metro Manila. Open daily 7 AM–9 PM.

More Resources

View All →